Evidence map›Paper›PMID 20557101›Full record

ArticleBiochemistry2010

Comparisons between chemical mapping and binding to isoenergetic oligonucleotide microarrays reveal unexpected patterns of binding to the Bacillus subtilis RNase P RNA specificity domain.

Ruiting Liang, Elzbieta Kierzek, Ryszard Kierzek, Douglas H Turner

Open access · bronzeAbstract readComparative Study
In one paragraph

Article in Biochemistry, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.5field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. The mechanisms of RNA SHAPE chemistry.Journal of the American Chemical Society · 2012
    Article
  8. Article
  9. Modeling and automation of sequencing-based characterization of RNA structure.Proceedings of the National Academy of Sciences of the United States of America · 2011
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Ruiting LiangDepartment of Chemistry, University of Rochester, Rochester, New York 14627, USA.
Elzbieta Kierzek
Ryszard Kierzek
Douglas H Turner
Institute of Bioorganic Chemistry, Polish Academy of Sciences · PLUniversity of Rochester · US

Funding

KINETIC AND SPECTROSCOPIC STUDIES OF NUCLEIC ACIDSR01GM022939 · NIGMS · UNIVERSITY OF ROCHESTER · PI TURNER, DOUGLAS H. · 1985 to 2016
$7.6M
NIGMS NIH HHS GM22939NIGMS NIH HHS R01 GM022939
6 · The paper itself

Abstract

Microarrays with isoenergetic pentamer and hexamer 2'-O-methyl oligonucleotide probes with LNA (locked nucleic acid) and 2,6-diaminopurine substitutions were used to probe the binding sites on the RNase P RNA specificity domain of Bacillus subtilis. Unexpected binding patterns were revealed. Because of their enhanced binding free energies, isoenergetic probes can break short duplexes, merge adjacent loops, and/or induce refolding. This suggests new approaches to the rational design of short oligonucleotide therapeutics but limits the utility of microarrays for providing constraints for RNA structure determination. The microarray results are compared to results from chemical mapping experiments, which do provide constraints. Results from both types of experiments indicate that the RNase P RNA folds similarly in 1 M Na(+) and 10 mM Mg(2+).

Indexed as

2-AminopurineBacillus subtilisBinding SitesOligonucleotide Array Sequence AnalysisOligonucleotide ProbesOligonucleotidesRibonuclease PRNASensitivity and Specificity2,6-diaminopurine2-AminopurineOligonucleotide ProbesOligonucleotidesRibonuclease PRNA

Identifiers

PMID20557101
PMCPMC2938832
OpenAlexW2026333579

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.